Clinical Trial

DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn if a handheld Mass Spectrometry device (MasSpec Pen) can accurately distinguish between masses, neurofibroma, and normal tissue during surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-17.
Status change: Not Yet Recruiting → Recruiting 2026-04-08
Trial Details
NCT Number NCT07298083
Lead Sponsor M.D. Anderson Cancer Center
Conditions Neurofibromas, MPNST
Enrollment 60 participants
Start Date 2026-04-02
Primary Completion 2030-04-30 (estimated)
Study Completion 2032-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-09